Professor in Pharmacy (p.t.)

Outi Salo-Ahen

Professor, Pharmacy
Email: outi.salo-ahen@abo.fi
Mobile: +358-469201190
Phone: +358-2-2154009


Peer-reviewed publications

A1 Journal article (refereed)
Inhibition of oncogenic kinases: an in vitro validated computational approach identified potential multi-target anticancer drugs (2019)
Nazia Ikram, Muhammad Usman Mirza, Michiel Vanmeert, Matheus Froeyen, Outi M. H. Salo-Ahen, Muhammad Tahir, Aamer Qazi, Sarfraz Ahmad
Biomolecules
View on publisher's site
A1 Journal article (refereed)
An ecoimmunological approach to study evolutionary and ancient links between coagulation, complement and innate immunity (2018)
Papareddy P, Kasetty G, Alyafei S, Smeds E, Salo-Ahen OMH, Hansson SR, Egesten A, Herwald H
Virulence
View on publisher's site
A1 Journal article (refereed)
Antigenic peptide prediction from E6 and E7 oncoproteins of HPV types 16 and 18 for therapeutic vaccine design using immunoinformatics and MD simulation analysis (2018)
Basit Jabbar, Shazia Rafique, Outi M. H. Salo-Ahen, Amjad Ali, Mobeen Munir, Muhammad Idrees, Muhammad Usman Mirza, Michiel Vanmeert, Syed Zawar Shah, Iqra Jabbar, Muhammad Adeel Rana
Frontiers in Immunology
View on publisher's site
A1 Journal article (refereed)
A rapid method for selecting suitable animal species for studying pathogen interactions with plasma protein ligands in vivo (2017)
Clément Naudin, Ariane Schumski, Outi M. H. Salo-Ahen, Heiko Herwald, Emanuel Smeds
Microbial Biotechnology
View on publisher's site
A1 Journal article (refereed)
High-Throughput Dual Screening Method for Ras Activities and Inhibitors (2017)
Kari Kopra, Arjan J. van Adrichem, Outi M. H. Salo-Ahen, Juha Peltonen, Krister Wennerberg, Harri Härmä
Analytical Chemistry
View on publisher's site
A2 Review article, Literature review, Systematic review
Tailored approaches in drug development and diagnostics: from molecular design to biological model systems (2017)
Cecilia Sahlgren, Annika Meinander, Hongbo Zhang, Fang Cheng, Maren Preis, Chunlin Xu, Tiina A. Salminen, Diana Toivola, Daniel Abankwa, Ari Rosling, Didem Şen Karaman, Outi M. H. Salo-Ahen, Ronald Österbacka, John E. Eriksson, Stefan Willför, Ion Petre, Jouko Peltonen, Reko Leino, Mark Johnson, Jessica Rosenholm, Niklas Sandler
Advanced Healthcare Materials
View on publisher's site
A1 Journal article (refereed)
Multivalent Interactions of Human Primary Amine Oxidase with the V and C2₂ Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase Activity (2016)
Heli Elovaara, Vimal Parkash, Ruth Fair-Mäkelä, Outi M. H. Salo-Ahen, Gabriela Guédez, Eva Bligt-Lindén, Janne Grönholm, Sirpa Jalkanen, Tiina A. Salminen
PLoS ONE
View on publisher's site
A1 Journal article (refereed)
Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins (2016)
Mirza MU, Rafique S, Ali A, Munir M, Ikram N, Manan A, Salo-Ahen OMH, Idrees M
Scientific Reports
View on publisher's site
A1 Journal article (refereed)
Dynamics of CYP51: Implications for Function and Inhibitor Design (2015)
Xiaofeng Yu, Vlad Cojocaru, Ghulam Mustafa, Outi M. H. Salo-Ahen, Galina I. Lepesheva, Rebecca C. Wade
Journal of Molecular Recognition
View on publisher's site
A1 Journal article (refereed)
Hotspots in an obligate homodimeric anticancer target. Structural and functional effects of interfacial mutations in human thymidylate synthase (2015)
Salo-Ahen OM, Tochowicz A, Pozzi C, Cardinale D, Ferrari S, Boum Y, Mangani S, Stroud RM, Saxena P, Myllykallio H, Costi MP, Ponterini G, Wade RC
Journal of Medicinal Chemistry
View on publisher's site
A1 Journal article (refereed)
Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase (2011)
Cardinale, Guaitoli, Tondi, Luciani, Henrich, Salo-Ahen, Ferrari, Marverti, Guerrieri, Ligabue, Frassineti, Pozzi, Mangani, Fessas, Guerrini, Ponterini, Wade, Costi
Proceedings of the National Academy of Sciences
View on publisher's site
A1 Journal article (refereed)
Computational approaches to identifying and characterizing protein binding sites for ligand design (2010)
Henrich S., Salo-Ahen O.M.H., Huang B, Rippmann F.F., Cruciani G., Wade R.C.
Journal of Molecular Recognition
View on publisher's site
A1 Journal article (refereed)
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding (2010)
Cardinale, Salo-Ahen, Guaitoli, Ferrari, Venturelli, Franchini, Battini, Ponterini, Wade, Costi
Protein Engineering, Design and Selection
View on publisher's site
A2 Review article, Literature review, Systematic review
Homodimeric enzymes as drug targets (2010)
Cardinale, Salo-Ahen, Ferrari, Ponterini, Cruciani, Carosati, Tochowicz, Mangani, Wade, Costi
Current Medicinal Chemistry
View on publisher's site
A2 Review article, Literature review, Systematic review
Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs (2010)
Garg, Henrich, Salo-Ahen, Myllykallio, Costi, Wade
Journal of Medicinal Chemistry
View on publisher's site
A2 Review article, Literature review, Systematic review
CB receptor ligands from plants (2008)
Woelkart, Salo-Ahen, Bauer
Current Topics in Medicinal Chemistry
View on publisher's site
A1 Journal article (refereed)
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data (2006)
Salo, Savinainen, Parkkari, Nevalainen, Lahtela-Kakkonen, Gynther, Laitinen, Järvinen, Poso
Journal of Medicinal Chemistry
View on publisher's site
A1 Journal article (refereed)
Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system (2006)
Saario, Poso, Juvonen, Järvinen, Salo-Ahen
Journal of Medicinal Chemistry
View on publisher's site
A1 Journal article (refereed)
Synthesis and CB1 receptor activities of dimethylheptyl derivatives of 2-arachidonoyl glycerol (2-AG) and 2-arachidonyl glyceryl ether (2-AGE) (2006)
Parkkari, Salo, Huttunen, Savinainen, Laitinen, Poso, Nevalainen, Järvinen
Bioorganic and Medicinal Chemistry
View on publisher's site
A1 Journal article (refereed)
Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes (2005)
Saario, Salo, Nevalainen, Poso, Laitinen, Järvinen, Niemi
Chemistry and Biology
View on publisher's site
A1 Journal article (refereed)
Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor (2005)
Savinainen, Kokkola, Salo, Poso, Järvinen, Laitinen
British Journal of Pharmacology
View on publisher's site
A2 Review article, Literature review, Systematic review
Targeting the cannabinoid CB2 receptor: mutations, modeling and development of CB2 selective ligands (2005)
Raitio, Salo, Nevalainen, Poso, Järvinen
Current Medicinal Chemistry
View on publisher's site
A1 Journal article (refereed)
The functional role of cysteines adjacent to the NRY motif of the human MT1 melatonin receptor (2005)
Kokkola, Salo, Poso, Laitinen
Journal of Pineal Research
View on publisher's site
A1 Journal article (refereed)
Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor (2005)
Salo, Raitio, Savinainen, Nevalainen, Lahtela-Kakkonen, Laitinen, Järvinen, Poso
Journal of Medicinal Chemistry
View on publisher's site
A1 Journal article (refereed)
Development of a 3D model for the human cannabinoid CB1 receptor (2004)
Salo, Lahtela-Kakkonen, Gynther, Järvinen, Poso
Journal of Medicinal Chemistry
View on publisher's site


Other publications

B1 Non-refereed journal articles
Molecular Modeling in Drug Design (2019)
Rebecca C. Wade, Outi M. H. Salo-Ahen
Molecules
View on publisher's site
B1 Non-refereed journal articles
Editorial (2008)
Salo-Ahen
Current Topics in Medicinal Chemistry
View on publisher's site
D4 Published development or research report or study
Simulations of human cannabinoid receptor model and bovine rhodopsin (2005)
Käsnänen H, Salo OM, Lahtela-Kakkonen M, Poso A


Other Research Activities


Last updated on 2019-02-08 at 08:09

Get in contact